CCO Treatment Updates
Diagnosing and Treating Chronic Hepatitis C: Management Tools for NPs and PAs
Virtual Presentations
Managing Therapeutic Challenges in Hepatitis C
|
CME Program Director: Emmet B. Keeffe, MD, MACP
|
|
Corinne L. Wentworth, PA-C, reviews clinical management of patients with hepatitis C, including nontraditional and difficult-to-manage patients.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss challenges in the diagnosis of HCV patients
- Review challenges in the assessment of HCV patients
- Describe management strategies for difficult-to-treat HCV patients with high risk of complications, including patients with depression and those with substance abuse problems
- Review data regarding the management of difficult-to-treat HCV patients with low risk for complications
|
CCO Slideset – Managing Therapeutic Challenges in Hepatitis C
 |
|
Format: Microsoft PowerPoint (.ppt) |
File size: 696 KB
| Date posted: 10/26/2006
|
HCV On-Treatment Virologic Monitoring: Impact on Treatment Decisions
|
CME Program Director: Emmet B. Keeffe, MD, MACP
- Ruth J. Corbett, MSN, ARNP, CCRC
|
|
|
Ruth J. Corbett, MSN, ARNP, CCRC, a gastroenterology nurse, reviews the use of virologic monitoring in the clinical management of patients infected with HCV.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify predictive factors that can impact the outcome of HCV patients on treatment
- List the different virologic markers of response to treatment
- Describe the importance of virologic monitoring on treatment outcomes
- Explain how to utilize clinical data to effectively individualize treatment strategies
|
CCO Slideset – HCV On-Treatment Virologic Monitoring: Impact on Treatment Decisions
 |
|
Format: Microsoft PowerPoint (.ppt) |
File size: 625 KB
| Date posted: 10/27/2006
|
Interactive Case Challenges
Management of a 54-Year-Old Man with HCV, Diabetes, and a History of Depression
|
CME Program Director: Emmet B. Keeffe, MD, MACP
Faculty: Anne Croghan, MN, ARNP
|
|
Anne Croghan, MN, ARNP, describes the treatment options for a patient with diabetes and a history of depression seeking treatment for chronic hepatitis C.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe management options for HCV-infected individuals with a history of depression
- Recount data regarding pretreatment assessment of individuals seeking therapy for HCV infection
- Review clinical data on the management of diabetes in individuals with chronic hepatitis C
|
Management of an HCV-Infected Patient Using Virologic Responses to Therapy
|
CME Program Director: Emmet B. Keeffe, MD, MACP
- Karen Dougherty, MSN, APRN, BC
|
|
|
Karen Dougherty, MSN, APRN, BC, discusses how response to HCV therapy can be used to make management decisions during treatment.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recount definitions of response to HCV therapy
- Review treatment guidelines in HCV genotype 1 patients
- Describe clinical data regarding determination of HCV treatment duration according to on-treatment virologic response
|
Interactive Algorithm Tool
HCV Treatment Guidelines Algorithm
An Interactive Decision Support Tool
|
|
This tool guides HCV treaters through baseline factors involved in making treatment decisions and emphasizes how responses to therapy affect on-treatment management decisions. The tool is based on current published treatment guidelines, and is enhanced with expert data analysis by Emmet B. Keeffe, MD, MACP, who highlights for users the new and evolving data that may weigh in on treatment decisions for HCV-infected patients.
Format: HTML
|
Disclaimer:
The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|